之前的SARS-COV-2感染和冠状动脉微血管功能障碍的结合:试点研究
Carole Kounga1, Daniel Huck1, Anina Sun1
1Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston MA, USA.
概括
轻微的COVID-19感染似乎不会导致长期冠状动脉微血管功能障碍 (CMD). 连续心脏PET/CT成像显示,与对照组相比,康复患者心肌流量储备 (MFR) 没有显著变化.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 医疗成像医学成像
背景情况:
- COVID-19与心血管问题有关,包括冠状动脉微血管功能障碍 (CMD).
- COVID-19对CMD和心肌流量储备 (MFR) 的长期影响需要进一步调查.
- 评估COVID-19后持续的心血管影响对于患者管理至关重要.
研究的目的:
- 为了评估COVID-19感染后患者中CMD状态和MFR的变化.
- 为了比较COVID-19幸存者与对照者的纵向MFR变化.
- 为了确定轻度的COVID-19是否会导致持续的冠状动脉微血管功能障碍.
主要方法:
- 一项单中心研究比较了35名COVID-19患者和70名对照者,使用连续心脏PET/CT扫描.
- 心肌流量储备 (MFR) < 2 定义的冠状动脉微血管功能障碍 (CMD).
- 线性和条件后勤回归分析了MFR和CMD状态的变化.
主要成果:
- 随访间隔的中位数为2.8年;大多数COVID-19患者有轻度症状,并已免疫.
- 在COVID-19患者和对照组之间没有观察到全球MFR变化的显著差异.
- 在这两组的大多数参与者中,CMD状态保持稳定 (83%对60%).
结论:
- 之前的证据表明了COVID-19-CMD联系,但这项研究没有发现MFR或CMD状态的显著纵向变化.
- 轻微的COVID-19感染似乎不会导致PET/CT检测到的持续性冠状动脉微血管功能障碍.
- 这些发现表明,在大多数轻度的COVID-19病例中,心血管恢复很可能是可能的.
更多相关视频
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
338
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Coronary Artery Disease II: Pathophysiology
817
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
817
Coronary Artery Disease I: Introduction
1.3K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Coronary Artery Disease IV: Preventive Measures
773
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
773
Coronary Artery Disease III: Clinical Manifestations
479
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
479
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
567
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
567


